User menu

Contributing role of extracellular vesicles on vascular endothelium haemostatic balance in cancer.

Bibliographic reference Bouvy, Céline ; Gheldof, Damien ; Chatelain, Christian ; Mullier, François ; Dogné, Jean-Michel. Contributing role of extracellular vesicles on vascular endothelium haemostatic balance in cancer.. In: Journal of Extracellular Vesicles, Vol. 3 (2014)
Permanent URL
  1. KHORANA A. A., FRANCIS C. W., CULAKOVA E., KUDERER N. M., LYMAN G. H., Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy, 10.1111/j.1538-7836.2007.02374.x
  2. Falanga A., Russo L., Epidemiology, risk and outcomes of venous thromboembolism in cancer : , 10.5482/ha-1170
  3. Gheldof Damien, Mullier François, Bailly Nicolas, Devalet Bérangère, Dogné Jean-Michel, Chatelain Bernard, Chatelain Christian, Microparticle bearing tissue factor: A link between promyelocytic cells and hypercoagulable state, 10.1016/j.thromres.2013.11.008
  4. Lacroix Romaric, Dignat-George Françoise, Microparticles as a circulating source of procoagulant and fibrinolytic activities in the circulation, 10.1016/j.thromres.2012.02.025
  5. Thomas Grace M., Panicot-Dubois Laurence, Lacroix Romaric, Dignat-George Françoise, Lombardo Dominique, Dubois Christophe, Cancer cell–derived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in vivo, 10.1084/jem.20082297
  6. Ratajczak J, Wysoczynski M, Hayek F, Janowska-Wieczorek A, Ratajczak M Z, Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication, 10.1038/sj.leu.2404296
  7. Anderson H Clarke, Mulhall Douglas, Garimella Rama, Role of extracellular membrane vesicles in the pathogenesis of various diseases, including cancer, renal diseases, atherosclerosis, and arthritis, 10.1038/labinvest.2010.152
  8. Gould Stephen J., Raposo Graça, As we wait: coping with an imperfect nomenclature for extracellular vesicles, 10.3402/jev.v2i0.20389
  9. Lefebvre H., Prevost G., Louiset E., MECHANISMS IN ENDOCRINOLOGY: Autocrine/paracrine regulatory mechanisms in adrenocortical neoplasms responsible for primary adrenal hypercorticism, 10.1530/eje-13-0308
  10. Hesketh Geoffrey G, Van Eyk Jennifer E, Tomaselli Gordon F, Mechanisms of Gap Junction Traffic in Health and Disease : , 10.1097/fjc.0b013e3181ba0811
  11. Rustom A., Nanotubular Highways for Intercellular Organelle Transport, 10.1126/science.1093133
  12. Berckmans R. J., Sturk A., van Tienen L. M., Schaap M. C. L., Nieuwland R., Cell-derived vesicles exposing coagulant tissue factor in saliva, 10.1182/blood-2010-06-290460
  13. Lv Lin-Li, Cao Yuhan, Liu Dan, Xu Min, Liu Hong, Tang Ri-Ning, Ma Kun-Ling, Liu Bi-Cheng, Isolation and Quantification of MicroRNAs from Urinary Exosomes/Microvesicles for Biomarker Discovery, 10.7150/ijbs.6100
  14. Huttner Hagen B., Janich Peggy, Köhrmann Martin, Jászai József, Siebzehnrubl Florian, Blümcke Ingmar, Suttorp Meinolf, Gahr Manfred, Kuhnt Daniela, Nimsky Christopher, Krex Dietmar, Schackert Gabriele, Löwenbrück Kai, Reichmann Heinz, Jüttler Eric, Hacke Werner, Schellinger Peter D., Schwab Stefan, Wilsch-Bräuninger Michaela, Marzesco Anne-Marie, Corbeil Denis, The Stem Cell Marker Prominin-1/CD133 on Membrane Particles in Human Cerebrospinal Fluid Offers Novel Approaches for Studying Central Nervous System Disease, 10.1634/stemcells.2007-0639
  15. LECHNER D., KOLLARS M., GLEISS A., KYRLE P. A., WELTERMANN A., Chemotherapy-induced thrombin generation via procoagulant endothelial microparticles is independent of tissue factor activity, 10.1111/j.1538-7836.2007.02788.x
  16. Grange C., Tapparo M., Collino F., Vitillo L., Damasco C., Deregibus M. C., Tetta C., Bussolati B., Camussi G., Microvesicles Released from Human Renal Cancer Stem Cells Stimulate Angiogenesis and Formation of Lung Premetastatic Niche, 10.1158/0008-5472.can-11-0241
  17. Fabbri M., Paone A., Calore F., Galli R., Gaudio E., Santhanam R., Lovat F., Fadda P., Mao C., Nuovo G. J., Zanesi N., Crawford M., Ozer G. H., Wernicke D., Alder H., Caligiuri M. A., Nana-Sinkam P., Perrotti D., Croce C. M., MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response, 10.1073/pnas.1209414109
  18. Jaiswal R., Gong J., Sambasivam S., Combes V., Mathys J.-M., Davey R., Grau G. E. R., Bebawy M., Microparticle-associated nucleic acids mediate trait dominance in cancer, 10.1096/fj.11-186817
  19. Castellana D, Hamostaseologie, 29, 51 (2009)
  20. Ghasemi Reza, Grassadonia Antonino, Tinari Nicola, Piccolo Enza, Natoli Clara, Tomao Federica, Iacobelli Stefano, Tumor-derived microvesicles: The metastasomes, 10.1016/j.mehy.2012.10.011
  21. Lima LG, Biosci Rep, 33, e00064 (2013)
  22. Falanga Anna, Panova-Noeva Marina, Russo Laura, Procoagulant mechanisms in tumour cells, 10.1016/j.beha.2008.12.009
  23. Gerotziafas Grigoris T., Galea Vassiliki, Mbemba Elisabeth, Khaterchi Amir, Sassi Mouna, Baccouche Hela, Prengel Claudie, van Dreden Patrick, Hatmi Mohamed, Bernaudin Jean François, Elalamy Ismail, Tissue factor over-expression by human pancreatic cancer cells BXPC3 is related to higher prothrombotic potential as compared to breast cancer cells MCF7, 10.1016/j.thromres.2011.07.049
  24. Mackman Nigel, Role of tissue factor in hemostasis and thrombosis, 10.1016/j.bcmd.2005.12.008
  25. Utsugi T, Cancer Res, 51, 3062 (1991)
  26. Morrissey James H., Davis-Harrison Rebecca L., Tavoosi Narjes, Ke Ke, Pureza Vincent, Boettcher John M., Clay Mary C., Rienstra Chad M., Ohkubo Y. Zenmei, Pogorelov Taras V., Tajkhorshid Emad, Protein-Phospholipid interactions in blood clotting, 10.1016/j.thromres.2010.01.027
  27. Langer F., Ruf W., Synergies of phosphatidylserine and protein disulfide isomerase in tissue factor activation : , 10.1160/th13-09-0802
  28. Yu J. L., Rak J. W., Shedding of tissue factor (TF)-containing microparticles rather than alternatively spliced TF is the main source of TF activity released from human cancer cells, 10.1111/j.1538-7836.2004.00972.x
  29. Aharon Anat, Brenner Benjamin, Microparticles, thrombosis and cancer, 10.1016/j.beha.2008.11.002
  30. Ameri A, Blood, 79, 3219 (1992)
  31. Connor D. E., Exner T., Ma D. D. F., Joseph J. E., The majority of circulating platelet-derived microparticles fail to bind annexin V, lack phospholipid-dependent procoagulant activity and demonstrate greater expression of glycoprotein Ib : , 10.1160/th09-09-0644
  32. Arraud N., Linares R., Tan S., Gounou C., Pasquet J.-M., Mornet S., Brisson A. R., Extracellular vesicles from blood plasma: determination of their morphology, size, phenotype and concentration, 10.1111/jth.12554
  33. de Agostini A. I., Localization of anticoagulantly active heparan sulfate proteoglycans in vascular endothelium: antithrombin binding on cultured endothelial cells and perfused rat aorta, 10.1083/jcb.111.3.1293
  34. Esmon C. T., Owen W. G., Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C., 10.1073/pnas.78.4.2249
  35. Esmon Charles T., Esmon Naomi L., The Link Between Vascular Features and Thrombosis, 10.1146/annurev-physiol-012110-142300
  36. Blann Andrew D., Endothelial cell activation markers in cancer, 10.1016/s0049-3848(12)70031-2
  37. Mesri Mehdi, Altieri Dario C., Leukocyte Microparticles Stimulate Endothelial Cell Cytokine Release and Tissue Factor Induction in a JNK1 Signaling Pathway, 10.1074/jbc.274.33.23111
  38. Aharon A, Thromb Haemost, 100, 878 (2008)
  39. Yu J., May L., Milsom C., Anderson G. M., Weitz J. I., Luyendyk J. P., Broze G., Mackman N., Rak J., Contribution of Host-Derived Tissue Factor to Tumor Neovascularization, 10.1161/atvbaha.108.175083
  40. Bode Ann M., Dong Zigang, The functional contrariety of JNK, 10.1002/mc.20348
  41. Bavendiek Udo, Libby Peter, Kilbride Meagan, Reynolds Rebecca, Mackman Nigel, Schönbeck Uwe, Induction of Tissue Factor Expression in Human Endothelial Cells by CD40 Ligand Is Mediated via Activator Protein 1, Nuclear Factor κB, and Egr-1, 10.1074/jbc.m204003200
  42. Pan Y., Liang H., Liu H., Li D., Chen X., Li L., Zhang C.-Y., Zen K., Platelet-Secreted MicroRNA-223 Promotes Endothelial Cell Apoptosis Induced by Advanced Glycation End Products via Targeting the Insulin-like Growth Factor 1 Receptor, 10.4049/jimmunol.1301790
  43. Bombeli T, Blood, 89, 2429 (1997)
  44. Pradier Amandine, Ettelaie Camille, The Influence of Exogenous Tissue Factor on the Regulators of Proliferation and Apoptosis in Endothelial Cells, 10.1159/000109074
  45. Varon David, Hayon Yael, Dashevsky Olga, Shai Ela, Involvement of platelet derived microparticles in tumor metastasis and tissue regeneration, 10.1016/j.thromres.2012.08.289
  46. Riedemann J, Macaulay V M, IGF1R signalling and its inhibition, 10.1677/erc.1.01280
  47. Abid Hussein M.N., Böing A.N., Biró É., Hoek F.J., Vogel G.M.T., Meuleman D.G., Sturk A., Nieuwland R., Phospholipid composition of in vitro endothelial microparticles and their in vivo thrombogenic properties, 10.1016/j.thromres.2007.08.005
  48. Pasquier J, Cancer Microenviron (2014)
  49. TERRISSE A. D., PUECH N., ALLART S., GOURDY P., XUEREB J. M., PAYRASTRE B., SIÉ P., Internalization of microparticles by endothelial cells promotes platelet/endothelial cell interaction under flow : Internalization of microparticles by endothelial cells, 10.1111/j.1538-7836.2010.04088.x
  50. Andre P, Blood, 96, 3322 (2000)
  51. Frenette P. S., Johnson R. C., Hynes R. O., Wagner D. D., Platelets roll on stimulated endothelium in vivo: an interaction mediated by endothelial P-selectin., 10.1073/pnas.92.16.7450
  52. Frenette Paul S., Denis Cécile V., Weiss Linnea, Jurk Kerstin, Subbarao Sangeetha, Kehrel Beate, Hartwig John H., Vestweber Dietmar, Wagner Denisa D., P-Selectin Glycoprotein Ligand 1 (Psgl-1) Is Expressed on Platelets and Can Mediate Platelet–Endothelial Interactions in Vivo, 10.1084/jem.191.8.1413
  53. Brodsky S. V., Endothelium-derived microparticles impair endothelial function in vitro, 10.1152/ajpheart.01172.2003
  54. Essayagh S, Thromb Haemost, 98, 831 (2007)
  55. Gawaz M, Role of platelets in coronary thrombosis and reperfusion of ischemic myocardium, 10.1016/j.cardiores.2003.11.036
  56. JY W., JIMENEZ J. J., MAURO L. M., HORSTMAN L. L., CHENG P., AHN E. R., BIDOT C. J., AHN Y. S., Endothelial microparticles induce formation of platelet aggregates via a von Willebrand factor/ristocetin dependent pathway, rendering them resistant to dissociation : EMP-platelet interaction, 10.1111/j.1538-7836.2005.01384.x
  57. Barry O P, Praticò D, Savani R C, FitzGerald G A, Modulation of monocyte-endothelial cell interactions by platelet microparticles., 10.1172/jci2592
  58. Bombeli Thomas, Schwartz Barbara R., Harlan John M., Adhesion of Activated Platelets to Endothelial Cells: Evidence for a GPIIbIIIa-dependent Bridging Mechanism and Novel Roles for Endothelial Intercellular Adhesion Molecule 1 (ICAM-1), αvβ3Integrin, and GPIbα, 10.1084/jem.187.3.329
  59. Elice F., Rodeghiero F., Hematologic malignancies and thrombosis, 10.1016/j.thromres.2011.11.034
  60. Wun Ted, White Richard H., Venous thromboembolism in patients with acute leukemia, lymphoma, and multiple myeloma, 10.1016/s0049-3848(10)70024-4
  61. Hunault-Berger M., Chevallier P., Delain M., Bulabois C.-E., Bologna S., Bernard M., Lafon I., Cornillon J., Maakaroun A., Tizon A., Padrazzi B., Ifrah N., Gruel Y., , Changes in antithrombin and fibrinogen levels during induction chemotherapy with L-asparaginase in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma. Use of supportive coagulation therapy and clinical outcome: the CAPELAL study, 10.3324/haematol.12948
  62. Blom Jeanet W., Malignancies, Prothrombotic Mutations, and the Risk of Venous Thrombosis, 10.1001/jama.293.6.715
  63. Ziegler Sophie, Sperr Wolfgang R., Knöbl Paul, Lehr Stephan, Weltermann Ansgar, Jäger Ulrich, Valent Peter, Lechner Klaus, Symptomatic venous thromboembolism in acute leukemia. Incidence, risk factors, and impact on prognosis, 10.1016/j.thromres.2004.07.016
  64. DE STEFANO V., SORÀ F., ROSSI E., CHIUSOLO P., LAURENTI L., FIANCHI L., ZINI G., PAGANO L., SICA S., LEONE G., The risk of thrombosis in patients with acute leukemia: occurrence of thrombosis at diagnosis and during treatment, 10.1111/j.1538-7836.2005.01467.x
  65. Mohren M, Markmann I, Jentsch-Ullrich K, Koenigsmann M, Lutze G, Franke A, Increased risk of venous thromboembolism in patients with acute leukaemia, 10.1038/sj.bjc.6602945
  66. Srkalovic Gordan, Cameron Marte G., Rybicki Lisa, Deitcher Steven R., Kattke-Marchant Kandice, Hussein Mohamad A., Monoclonal gammopathy of undetermined significance and multiple myeloma are associated with an increased incidence of venothromboembolic disease, 10.1002/cncr.20405
  67. Rickles Frederick R., Levine Mark N., Epidemiology of Thrombosis in Cancer, 10.1159/000046583
  68. Falanga A, Hematology Am Soc Hematol Educ Program, 2012, 571 (2012)
  69. Haim Nissim, Lanir Naomi, Hoffman Ron, Haim Amir, Tsalik Medi, Brenner Benjamin, Acquired activated protein C resistance is common in cancer patients and is associated with venous thromboembolism, 10.1016/s0002-9343(00)00691-4
  70. NEGAARD H. F. S., IVERSEN P. O., ØSTENSTAD B., MOWINCKEL M. C., SANDSET P. M., Increased acquired activated protein C resistance in unselected patients with hematological malignancies, 10.1111/j.1538-7836.2008.03060.x
  71. Rosendaal FR, Blood, 85, 1504 (1995)
  72. Thaler Johannes, Pabinger Ingrid, Sperr Wolfgang R., Ay Cihan, Clinical evidence for a link between microparticle-associated tissue factor activity and overt disseminated intravascular coagulation in patients with acute myelocytic leukemia, 10.1016/j.thromres.2013.12.029
  73. Auwerda J. J. A., Yuana Y., Osanto S., de Maat M. P. M., Sonneveld P., Bertina R. M., Leebeek F. W. G., Microparticle-associated tissue factor activity and venous thrombosis in multiple myeloma : , 10.1160/th10-03-0187
  74. Duchemin Jérôme, Ugo Valérie, Ianotto Jean-Christophe, Lecucq Lydie, Mercier Bernard, Abgrall Jean-François, Increased circulating procoagulant activity and thrombin generation in patients with myeloproliferative neoplasms, 10.1016/j.thromres.2010.06.025
  75. Blann A. D., Gurney D., Wadley M., Bareford D., Stonelake P., Lip G. Y. H., Increased soluble P-selectin in patients with haematological and breast cancer: a comparison with fibrinogen, plasminogen activator inhibitor and von Willebrand factor : , 10.1097/00001721-200101000-00007
  76. SWYSTUN L. L., SHIN L. Y. Y., BEAUDIN S., LIAW P. C., Chemotherapeutic agents doxorubicin and epirubicin induce a procoagulant phenotype on endothelial cells and blood monocytes, 10.1111/j.1538-7836.2009.03300.x
  77. Fu Y., Zhou J., Li H., Cao F., Su Y., Fan S., Li Y., Wang S., Li L., Gilbert G. E., Shi J., Daunorubicin induces procoagulant activity of cultured endothelial cells through phosphatidylserine exposure and microparticles release : , 10.1160/th10-02-0102
  78. Lyman Gary H., Khorana Alok A., Kuderer Nicole M., Lee Agnes Y., Arcelus Juan Ignacio, Balaban Edward P., Clarke Jeffrey M., Flowers Christopher R., Francis Charles W., Gates Leigh E., Kakkar Ajay K., Key Nigel S., Levine Mark N., Liebman Howard A., Tempero Margaret A., Wong Sandra L., Prestrud Ann Alexis, Falanga Anna, Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update, 10.1200/jco.2013.49.1118
  79. Zhang Jun, DeFelice Albert F., Hanig Joseph P., Colatsky Thomas, Biomarkers of Endothelial Cell Activation Serve as Potential Surrogate Markers for Drug-induced Vascular Injury, 10.1177/0192623310378866